Starling Oncology (STLNW) EPS (Diluted) Growth (3y) (2023 - 2026)
Powered by 
Analysis
Starling Oncology (STLNW) EPS (Diluted) Growth (3y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.90 Bn | 11.22 Bn | 1.16 Bn | 25.34% |
| 2 | RadNet | 5.52 Bn | 4.79 Bn | 88.08 Mn | 2.42% |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn | 18.42% |
| 4 | Concentra Group Holdings Parent | 4.26 Bn | 4.10 Bn | 192.10 Mn | 0.44% |
| 5 | Privia Health | 2.57 Bn | 2.15 Bn | - | 13.09% |
| 6 | Pediatrix Medical | 2.15 Bn | 1.74 Bn | - | 12.67% |
| 7 | Progyny | 2.11 Bn | 1.87 Bn | 89.30 Mn | 31.85% |
| 8 | Surgery Partners | 1.84 Bn | 1.63 Bn | 622.10 Mn | -20.16% |
| 9 | U S Physical Therapy | 1.17 Bn | 1.15 Bn | 41.94 Mn | -3.01% |
| 10 | Starling Oncology | 4.13 Mn | -36.96 Mn | 27.17 Mn | 29.47% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29.47% |
| Mar 31, 2026 | 63.07% |
| Dec 31, 2025 | 20.13% |
| Sep 30, 2025 | -61.40% |
| Jun 30, 2025 | -26.19% |
| Mar 31, 2025 | -41.35% |
| Dec 31, 2024 | 1.29% |
| Sep 30, 2024 | -144.21% |
| Jun 30, 2024 | -22.31% |
| Mar 31, 2024 | -70.48% |
| Dec 31, 2023 | -15,447.69% |
| Sep 30, 2023 | -41.29% |